Last reviewed · How we verify
HPP737
At a glance
| Generic name | HPP737 |
|---|---|
| Sponsor | Newsoara Biopharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- HPP737 Substance Balance Study in Human (NA)
- Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HPP737 CI brief — competitive landscape report
- HPP737 updates RSS · CI watch RSS
- Newsoara Biopharma Co., Ltd. portfolio CI